en
Scientific article
English

Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients

Published inClinical Infectious Diseases, vol. 70, no. 2, p. 297-303
Publication date2020
Abstract

The rate of acquired HIV-1 drug resistance (ADR) has fallen dramatically since introduction of combined antiretroviral therapy (cART) in Switzerland. However, clinical experience indicates that there are still patients at risk of newly acquiring drug resistance despite having access to cART. Here, we characterized risk factors for ADR, in order to improve patient care, prevent emergence of drug resistance, and treatment failure.

Keywords
  • HIV-1 drug resistance
  • Antiretroviral therapy
  • Risk factors
  • Socioeconomic factors
Funding
  • Swiss National Science Foundation - 179 571
  • Swiss National Science Foundation - 148522
Citation (ISO format)
ABELA, Irene A et al. Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients. In: Clinical Infectious Diseases, 2020, vol. 70, n° 2, p. 297–303. doi: 10.1093/cid/ciz178
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1058-4838
231views
3downloads

Technical informations

Creation11/05/2019 4:05:00 PM
First validation11/05/2019 4:05:00 PM
Update time03/15/2023 9:57:37 PM
Status update03/15/2023 9:57:36 PM
Last indexation01/17/2024 9:52:41 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack